Cingulate CING
NASDAQ CING
$4.46 -0.10 (-2.14%)
As of: Nov 11, 2026 · 11:15 AM EST

Cingulate (CING) Revenue (2024 - 2026)

Updated

Analysis

Cingulate (CING) Revenue (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 24.40 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 25.40 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 17.40 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 18.09 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 15.07 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 10.37 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 8.30 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 16.58 Bn
10 Cingulate 63.36 Mn -8.01 Mn - -141,276.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -141,276.00
Mar 31, 2026 -536,837.00
Jun 30, 2025 -138,761.00
Mar 31, 2025 -96,784.00
Jun 30, 2024 -3,497.00
Mar 31, 2024 -24,260.00
API Access

Cingulate Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=CING&period=max&api_key=YOUR_API_KEY